| Financial Year |
March 31 2023 |
| Monetary Funds |
624,267,874.00 |
| Held-for-trading Financial Assets |
10,000,000.00 |
| Notes Receivable |
-- |
| Accounts Receivable |
222,666,829.31 |
| Advances to Suppliers |
463,961,608.52 |
| Other Receivables |
27,528,568.84 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
983,125.00 |
| Dividend Receivable |
-- |
| Inventories |
272,737,548.09 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
80,739,872.02 |
| Total Current Assets |
2,678,465,493.53 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
23,037,802.16 |
| Long-term Equity Investment |
112,356,534.36 |
| Investment Properties |
6,970,505.88 |
| Fixed Assetes |
578,771,823.55 |
| Under-construction Projects |
200,956,767.89 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
76,817,454.01 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
12,001,807.75 |
| Deferred Income Tax Assets |
43,310,787.53 |
| Other Non-Current Assets |
5,674,715.56 |
| Sub-Total of Non-Current Assets |
1,343,712,025.52 |
| Total Assets |
4,022,177,519.05 |
| Short-Term Loans |
221,093,426.06 |
| Trading Financial liabilities |
-- |
| Notes Payable |
104,223,142.45 |
| Accounts Payable |
707,412,057.38 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
9,846,140.16 |
| Taxes Payable |
8,096,806.69 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
49,918,152.64 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
75,487,088.18 |
| Other Current Liabilities |
66,500,530.99 |
| Sub-Total of Current Liabilities |
1,882,166,781.90 |
| Long-term Loans |
19,600,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
158,269,832.18 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
36,263,954.16 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
295,500,370.69 |
| Total Liabilities |
2,177,667,152.59 |
| Paid-In Capital(Or Share Stock) |
1,728,029,133.00 |
| Capital Surplus |
1,647,464,357.78 |
| Surplus Reserve |
41,192,500.70 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-1,617,844,064.68 |
| Minority Stockholder's Interest |
9,034,350.05 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,835,476,016.41 |
| Owner's Equity（Stockholder's Equity） |
1,844,510,366.46 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
4,022,177,519.05 |
